Cargando…
Investigating the Current Status of SARS-CoV-2 Antibodies in Hospital Staff
The coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 had reported over 676 million cases by March 2023. The main aim of this study is to investigate whether the levels of anti-S and anti-N antibodies could precisely indicate the degree of protection against SARS-CoV-2 and affect the...
Autores principales: | Liu, Keh-Sen, Yang, Yu-Ying, Hwang, Kai-Lin, Wu, Hsing-Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221425/ https://www.ncbi.nlm.nih.gov/pubmed/37242357 http://dx.doi.org/10.3390/pathogens12050688 |
Ejemplares similares
-
Current status of therapeutic monoclonal antibodies against SARS-CoV-2
por: Kumar, Sanjeev, et al.
Publicado: (2021) -
Correction: Current status of therapeutic monoclonal antibodies against SARS-CoV-2
por: Kumar, Sanjeev, et al.
Publicado: (2022) -
Prevalence of SARS-CoV-2 infection and SARS-CoV-2-specific antibody detection among healthcare workers and hospital staff of a university hospital in Colombia
por: Caballero, Nohemí, et al.
Publicado: (2022) -
Hospital-wide SARS-CoV-2 antibody screening of staff in a university psychiatric centre in Belgium
por: El Abdellati, Kawtar, et al.
Publicado: (2021) -
Snapshot PCR surveillance for SARS-CoV-2 in hospital staff in England
por: Brown, Colin S, et al.
Publicado: (2020)